HIV

  • Hepatitis C and HIV prophylaxis: microwave reduces viral transmission in the drugs scene

    PD Dr. Eike Steinmann und Anindya Siddharta. TWINCORE/Romy Weller

    Infections with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) among people who inject drugs (PWID) are a global health problem. For example, sharing of drug preparation equipment within this population contributes to more than 80% of newly acquired HCV infections. As a response to these circumstances, scientists at TWINCORE validated a simple and safe method to reduce the risk of viral transmission, namely by microwave irradiation. This method has been published recently in Scientific Reports.

  • Inflammation Triggers Unsustainable Immune Response to Chronic Viral Infection

    Under the influence of interferons, chronic viral infections cause strong inflammation. This causes the B cells to initiate an inadequate immune response. Department of Biomedicine, University of Basel

    Scientists at the University of Basel discovered a fundamental new mechanism explaining the inadequate immune defense against chronic viral infection. These results may open up new avenues for vaccine development. They have been published in the journal “Science Immunology”.

  • New antibody therapy permanently blocks SIV infection

    Prof. Dr. Lutz Walter is Head of the Primate Genetics Laboratory at the German Primate Center and co-author of the study. Photo: Karin Tilch

    An international research team has developed an effective treatment strategy against the HIV-like Simian Immunodeficiency Virus (SIV) in rhesus macaques